Mid Illinois Hematology & Oncology Associates, Ltd /ID# 230536

Normal, Illinois 61761

0 studies enrolling now · 1 studies all time

What they study most

Myelofibrosis (MF)

Studies at this site

• A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis — Completed